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Intestinal tuberculosis (ITB) involves the ileocaecum in the majority 
of cases with upper gastrointestinal tract tuberculosis accounting 
for less than 3% of all cases.1 Gallbladder TB, in particular, is very 
rare, with few cases reported in the literature. ITB results from 
haematogenous spread or spread from contiguous lymph nodes 
or swallowed infected sputum.2 Why ITB preferentially affects the 
ileocaecum is unclear, but proposed mechanisms include bowel stasis 
in the terminal ileum, due to the ileocaecal valve, and the high density 
of lymphoid tissue found in the terminal ileum.
Bile acids are the major constituent of bile and the primary bile 
acids, cholic and chenodeoxycholic acid, and secondary bile acids, 
lithocholic and deoxycholic acid, make up more than 95% of the bile 
acid pool. Bile acids have a number of biological effects, including 
generation of reactive oxygen species, a detergent action on lipid-
containing cell membranes and antimicrobial effects. Enterohepatic 
circulation of bile acids results in efficient reabsorption of bile acids, 
resulting in a concentration gradient between proximal small intestine 
and terminal ileum. Only 10% of bile acids escape reabsorption and 
studies have shown that the bile acid concentration in the caecum is 
below the micellisation concentration.3 Could the high concentration 
of bile acids in the gallbladder and the proximal intestine be 
protective and explain the anatomical distribution of ITB?
We determined the effect of physiological concentrations of bile 
acids on the in vitro growth of Mycobacterium tuberculosis (MTB).
Methods
The 4 major bile acids, lithocolic acid, cholic acid, deoxycholic 
acid and chenodeoxycholic acid (all supplied by Sigma Aldrich, 
SA) were selected for study. Individual bile acids were added to 
standard Lowenstein-Jensen (LJ) media to achieve physiological 
concentrations,4 as shown in Table 1. A fifth LJ-bile acid solution 
was prepared using all 4 bile acids. Due to difficulties in solubilising 
the combination of 4 bile acids at physiological concentrations, the 
concentration of each had to be reduced by 50% in this LJ slope.
Each ‘physiological’ LJ-bile acid solution was subsequently double-
diluted 4 times with pure LJ solution, to achieve a decreasing 
concentration of bile acid in the culture medium. A standard 
inoculum (0.5 McFarland) of MTB H37Rv was inoculated onto each 
LJ slope in triplicate, as well as onto LJ slopes with no bile salts added. 
The slopes were incubated at 37°C for 8 weeks. Mycobacterial growth 
was measured at 2 and 8 weeks in a semiquantitative fashion using 
cut-offs of >5, >10, >20, >100 colony-forming units (CFUs) per slope. 
Results 
There were >100 CFUs of typical MTB colonies on the control slopes 
at both 2 and 8 weeks. Similarly, all lithocolic acid cultures showed 
growth of >100 CFUs at 2 and 8 weeks. 
Three of the bile acids alone (chenodeoxycholic acid, deoxycholic 
acid and cholic acid) and the combination of all 4 showed inhibition 
of growth at 2 and 8 weeks. Chenodeoxycholic acid appeared to be 
the most active of the bile salts, based on the results at 8 weeks, with 
inhibition of growth even at a 5-fold dilution (1.375 mg/ml). As 
can be seen from Figs 1 - 4, a concentration-dependent effect was 
evident for the above bile acids alone and in combination. There 
was complete inhibition of growth of MTB at physiological and sub-
physiological concentrations of the above 3 bile salts at both 2 and 8 
weeks. Results were largely reproducible across all three experiments.
Four cultures were lost to contamination. These included a 
deoxycholic acid culture at 8 mg/ml and 3 cholic acid cultures with 
the following concentrations: 16 mg/ml, 8 mg/ml and 4 mg/ml.
The effect of physiological concentrations of bile acids on 
the in vitro growth of Mycobacterium tuberculosis
D Epstein, K Mistry, A Whitelaw, G Watermeyer, K E Pettengell 
Background. Intestinal tuberculosis occurs mainly in the terminal 
ileum and caecum, where the concentration of bile acids is lowest, 
and rarely in the upper digestive tract. 
Objectives. We examined the effect of physiological concentrations 
of bile acids on the in vitro growth of Mycobacterium tuberculosis 
(MTB).
Methods. The 4 major bile acids, lithocolic acid, cholic acid, 
deoxycholic acid and chenodeoxycholic acid, were added to 
individual Lowenstein-Jensen (LJ) culture media at physiological 
concentrations. A combined LJ medium was also prepared using 
all 4 bile acids. These were double-diluted 4 times by the addition 
of LJ media. Each culture medium was inoculated with the H37Rv 
strain of MTB and incubated at 37°C for 8 weeks. MTB growth was 
measured at 2 and 8 weeks in a semiquantitative fashion using cut-
offs of >5, >10, >20, >100 colony-forming units.
Results. All lithocolic acid cultures showed uninhibited TB 
growth at 2 and 8 weeks. Chenodeoxycholic acid, deoxycholic acid 
and cholic acid alone, and in combination, showed concentration-
dependent inhibition of MTB growth at 2 and 8 weeks. Four 
cultures were lost to contamination.
Conclusions. Certain bile acids alone and in combination, at 
physiological concentrations, inhibit the growth of MTB in vitro. 
This might explain why intestinal TB occurs in the ileocaecum in 
the majority of cases and why gallbladder TB is very rare.
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Discussion
TB of the upper gastrointestinal tract is rare, and isolated TB of the 
gallbladder very rare, with 5 patients making up the largest case 
series.5 Gallbladder TB usually occurs as an unexpected finding 
following surgery for benign gallbladder disease5 or in the context 
of immune suppression.6 In view of the rarity of gallbladder TB, 
it is reasonable to consider the gallbladder somewhat resistant to 
tuberculous infection.
We have demonstrated that the bile acids chenodeoxycholic 
acid, deoxycholic acid and cholic acid, alone or in combination, at 
physiological concentrations, inhibit the growth of MTB in vitro. 
The anti-mycobacterial effect could be due to the disruption of the 
lipid-containing mycobacterial cell wall. A concentration-dependent 
effect was demonstrated and was reproducible. The 8-week results 
for cholic acid are somewhat surprising, as there seemed to be no 
effect at 16 mg/ml, but there was an observable inhibitory effect at 
Table 1. Dilution protocol of bile acids in Lowenstein-Jensen medium 
Lowenstein-Jensen medium with bile acid additives 
Lithocolic acid 
(mg/ml)
Cholic acid 
(mg/ml)
Chenodeoxycholic 
acid (mg/ml)
Deoxycholic acid 
(mg/ml)
Combined bile acids 
in physiological ratio
(mg/ml) 
Dilution 1 2 32 22 12 - 
Dilution 2 1 16 11 6 35
Dilution 3 0.5 8 5.5 3 17.5 
Dilution 4 0.25 4 2.75 1.5 8.75
Dilution 5 0.125 2 1.375 0.75 4.375 
Dilution 6 - - - - 2.188
Bil acid physiological 
concentration based on 
gallbladder aspirates4
[mean±SD] (mg/ml) 
[1.5±1.4] [18.3±12.4] [11.5±4.9]  [6.7±4.3] 
Fig. 1. Chenodeoxycholic acid: MTB growth.
Fig. 2. Deoxycholic acid: MTB growth.
Fig. 3. Cholic acid: MTB growth.
Fig. 4. Combined bile acids: MTB growth.
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4 mg/ml. One possible explanation may be related to the difficulties 
in getting bile salts to dissolve in the LJ medium, which may have 
resulted in a non-homogeneous solution initially. Similarly, lithocolic 
acid is the most hydrophobic of the bile acids; reduced solubility in 
LJ medium may be one explanation for the lack of activity of this bile 
salt. Alternatively, lithocholic acid may have no intrinsic ability to 
inhibit mycobacterial growth.
In light of these findings, the interesting possibility is that 
ursodeoxycholic acid, used as a therapeutic bile acid in cholestatic 
disorders, may have antimycobacterial effects, but in vitro studies will 
be required to explore this.
We have demonstrated that bile acids at physiological 
concentrations inhibit the growth of MTB, raising the possibility that 
the high concentration of bile acids in the gallbladder and proximal 
intestine may be protective against MTB, while explaining the 
predilection of MTB for the terminal ileum and caecum, where bile 
acid concentrations are at their lowest.
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